Symposium 7: DMT2 with sarcopenia, should we treat them differently?
In this age that facilitates sedentary lifestyle habits, from primary prevention to the treatment of all clinical forms of diabetes, a lifestyle change that includes physical activity and regular exercise cannot be lacking1. The background of mitochondrial dysfunction2, especially in the skeletal m...
Main Author: | Cristina De La Mata |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Sello Editorial Lugones
2022-09-01
|
Series: | Revista de la Sociedad Argentina de Diabetes |
Subjects: | |
Online Access: | https://revistasad.com/index.php/diabetes/article/view/565 |
Similar Items
-
Simposio 7: Diabetes mellitus tipo 2 con sarcopenia, ¿debemos tratarlas de manera diferente?
by: Cristina De La Mata
Published: (2022-09-01) -
Symposium 2: Should we treat neuropathy in T2DM differently?
by: Graciela Fuente
Published: (2022-09-01) -
Symposium 13: Reach and meaning of the sarcopenia in T2D
by: Claudio González
Published: (2020-11-01) -
Sarcopenia in patients with diabetes mellitus
by: Yannis Dionyssiotis, et al.
Published: (2022-08-01) -
Diabetes Mellitus Should Be Considered While Analysing Sarcopenia-Related Biomarkers
by: Justyna Rentflejsz, et al.
Published: (2024-02-01)